Skip to main content

Table 2 Clinicopathological profiles of endometrial intraepithelial carcinomas

From: Endometrial intraepithelial carcinoma in association with polyp: review of eight cases

Case

EIC location

Immunohistochemistry

FIGO stage

Outcome (periode)

P53a

MIB-1b

ERc

PgRd

1

polyph

+

30

+

+

IA

DFi (66 months)

2

polyp & endometrium

+

60

-

-

IA

DF (65 months)

3f

polyp & endometrium

+

35

-

-

IA

DF (36 months)

4

polyp

+

30

-

-

IA

DF (30 months)

5

polyph & endometrium

+

45

-

+

IA

DF (39 months)

6

polyp

+

25

-

-

IA

DF (39 months)

7 g

polyp

-

30

-

-

IA

DODj (44 months)

8

polyph & endometrium

-

70

-

-

IA

DF (12 months)

  1. a:+, strongly positive cells more than 80%.
  2. b: index of positive cells(%), c: +, positive cells more than 80%.
  3. d: +, positive cells more than 80%.
  4. e: since initial diagnosis.
  5. f: history of breast cancer with Tamoxifen administration.
  6. g: autopsy performed.
  7. h: with stromal invasion, i: disease free, j: death on disease.